A
EW icon

AlphaQuest’s Edwards Lifesciences EW Stock Holding History

AlphaQuest’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,849
Closed -$328K – 687
2025
Q4 		$328K Sell
3,849
-2,351
-38% -$193K 0.02% 1143
2025
Q3 		$482K Buy
+6,200
New +$484K 0.03% 813
2025
Q2 		– Sell
-11,637
Closed -$843K – 2115
2025
Q1 		$843K Buy
11,637
+6,763
+139% +$484K 0.09% 342
2024
Q4 		$361K Sell
4,874
-1,276
-21% -$89.3K 0.05% 628
2024
Q3 		$406K Buy
+6,150
New +$447K 0.04% 753
2024
Q2 		– Sell
-14
Closed -$1.34K – 1672
2024
Q1 		$1.34K Sell
14
-12,538
-100% -$1.05M ﹤0.01% 1202
2023
Q4 		$957K Buy
+12,552
New +$873K 0.2% 157

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

AlphaQuest's EW Position: Q1 2026 in Review

AlphaQuest sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 3,849 shares — an estimated $328K sold.

AlphaQuest first reported a position in EW in Q4 2023 and held it in 7 quarters. The position peaked at $957K in Q4 2023. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • AlphaQuest reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 3,849 Edwards Lifesciences shares in Q1 2026, an estimated $328K.
  • AlphaQuest first reported a position in Edwards Lifesciences in Q4 2023 and held it in 7 quarters.
  • AlphaQuest's Edwards Lifesciences position peaked at $957K in Q4 2023.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.